This stock is not acting right for one with a strong buy rating. May be time to get rid of it.
b
Volume is still high but slowing a bit. It has been suppressed so long that a run is still due even absent a significant catalyst, but not over $10 before February.
Mutual fund Stake Shares
owned Total value ($) Shares
bought / sold Total
change
Aescap 2.0 4.95% 2,480,883 10,419,709 +2,480,883 --
PGIM Jennison Health Sciences Fun... 3.44% 1,725,935 7,248,927 0 0.00%
Wellington Mgmt. Funds (IE) Plc -... 1.52% 764,000 3,208,800 +84,000 +12.35%
Hoofbosch Beleggingsfonds 0.80% 400,000 1,680,000 +140,000 +53.85%
Candriam Equities L - Biotechnolo... 0.77% 387,000 1,625,400 +50,000 +14.84%
Fidelity Funds SICAV - European S... 0.66% 331,203 1,391,053 +2 +0.00%
JPMorgan Funds - Thematics - Gene... 0.50% 251,119 1,054,700 +251,119 --
CI Global Health Sciences Corpora... 0.44% 221,360 929,712 0 0.00%
Vanguard International Explorer F... 0.38% 189,167 794,501 +189,167 --
Xtrackers - S&P 500 Swap UCITS ET... 0.36% 180,922 759,872 0 0.00%
Shares Current
Shares Change
(Percent) Ownership
(Percent) Change
(Percent)
2020-02-14 13G/A RTW INVESTMENTS, LP 4,779,135 9.96
2020-02-12 13G/A ADAGE CAPITAL PARTNERS GP, L.L.C. 4,571,319 9.26
2020-02-11 13G/A UBS Group AG
2020-02-07 13G/A JENNISON ASSOCIATES LLC 2,630,626 5.30
2020-02-03 13G/A PRUDENTIAL FINANCIAL INC 2,630,626 5.30
2020-01-29 13G/A GOLDMAN SACHS GROUP INC 3,506,364 7.10
2020-01-28 13G/A WELLINGTON MANAGEMENT GROUP LLP 5,495,128 11.13
2020-01-27 13G/A Inspirational Visions B.v. 2,499,294 5.10
2019-02-14 13G/A Sofinnova Partners SAS 2,764,194 7.10
2019-02-12 13G/A Invus Public Equities, L.P. 1,400,000 3.62
2018-04-12 13G Aescap Medical Investments B.v. 1,801,200 5.60
2018-02-14 13G/A Redmile Group, LLC 1,558,392 4.89
2018-02-13 13G/A ORBIMED ADVISORS LLC 662,287 2.08
2017-10-11 13G Jdg B.v. 2,646,285 10.50
2016-04-11 13G/A FMR LLC 237,916 1.02